New York, NY 10065
United States
Memorial Sloan Kettering Cancer Center
oligoprogression, oligoprogressive, stereotactic body radiotherapy, SBRT, stereotactic ablative radiotherapy, SABR, non-small-cell lung cancer, NSCLC, breast cancer, ctDNA, cfDNA, circulating tumor DNA, liquid biopsy
ALK, Brain Metastases, Non-Small Cell Lung Cancer, Central Nervous System, CNS Radiation
Radiotherapy outcome modelling, prescription determination, tumor control probability, normal tissue complication probability, radiotherapy analysis software
immunotherapy, Targeted Therapy, HER2 mutation, ctDNA, NSCLC